| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/23/2011 | CN101981011A Pyridyl derivatives as CFTR modulators |
| 02/23/2011 | CN101981010A 酰胺化合物 Amide compounds |
| 02/23/2011 | CN101980721A Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same |
| 02/23/2011 | CN101980716A Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents |
| 02/23/2011 | CN101980713A Anti-tumor agent comprising cytidine derivative and carboplatin |
| 02/23/2011 | CN101980705A Use of benzophenone derivative or salt thereof and TNF alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 02/23/2011 | CN101980017A Anti-TNF antibodies, compositions, methods and uses |
| 02/23/2011 | CN101979572A Preparation for South China Sea conus striatus toxin S4.3 and application |
| 02/23/2011 | CN101979093A Composition comprising polypeptide-drug substance and other poorly absorbed active ingredient and its use |
| 02/23/2011 | CN101979082A Medicament for treating cyclomastopathy and preparation method and application thereof |
| 02/23/2011 | CN101978990A Schisandra extract and preparation method and application thereof |
| 02/22/2011 | US7894769 Wireless microphone communication system |
| 02/22/2011 | US7893280 2,4-disubstituted thiazolyl derivatives |
| 02/22/2011 | US7893242 Oligonucleotide compositions and their use to induce apoptosis |
| 02/22/2011 | US7893211 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization; |
| 02/22/2011 | US7893209 Slo2, novel potassium channel proteins from human brain |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893087 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 02/22/2011 | US7893084 Viral polymerase inhibitors |
| 02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
| 02/22/2011 | US7893068 Physiologically active substances |
| 02/22/2011 | US7893049 Thiazolyl-dihydro-indazole |
| 02/22/2011 | US7892834 Cellular signal-responsive gene transcriptional regulation system |
| 02/22/2011 | US7892828 Method of identifying a MHC class I restricted T cell response |
| 02/22/2011 | US7892818 Method and kit for the determination of cellular activation profiles |
| 02/22/2011 | US7892556 Apoptotically active peptides |
| 02/22/2011 | US7892549 Treatment with anti-ErbB2 antibodies |
| 02/22/2011 | CA2501021C Pantethine-containing particulate |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2474823C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 02/22/2011 | CA2470575C Spiroazacyclic compounds as monoamine receptor modulators |
| 02/22/2011 | CA2468133C Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 02/22/2011 | CA2463968C Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 02/22/2011 | CA2446314C Liver x receptor agonists |
| 02/22/2011 | CA2441566C Blood cell production via activation of the hemoglobin scavenger receptor |
| 02/22/2011 | CA2435503C Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 02/22/2011 | CA2432289C Interleukin-18 inducer |
| 02/22/2011 | CA2423833C Viruses targeted to hypoxic cells and tissues |
| 02/22/2011 | CA2410193C Neuronal serine-threonine protein kinase |
| 02/22/2011 | CA2403139C Novel 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and medicaments containing these compounds |
| 02/22/2011 | CA2398163C Therapeutic morpholino-substituted compounds |
| 02/22/2011 | CA2328438C Heterocyclically substituted amides, their production and their use |
| 02/22/2011 | CA2319198C Substituted oxoazaheterocyclyl factor xa inhibitors |
| 02/22/2011 | CA2263409C High molecular weight polymer-based prodrugs |
| 02/22/2011 | CA2143491C A novel peptide related to human programmed cell death and dna encoding it |
| 02/17/2011 | WO2011019413A1 Pharmaceutical composition and administrations thereof |
| 02/17/2011 | WO2011019134A2 Vaccine composition including salmonella microorganism variants for preventing fowl typhoid |
| 02/17/2011 | WO2011019060A1 Hedgehog signal inhibitor |
| 02/17/2011 | WO2011018894A1 Pyrrolopyrimidine derivatives as potassium channel modulators |
| 02/17/2011 | WO2011018865A1 Method for manufacturing a functional gel |
| 02/17/2011 | WO2010122980A8 NOVEL THYROID HORMONE β RECEPTOR AGONIST |
| 02/17/2011 | US20110039949 Pet food product and method of manufacture |
| 02/17/2011 | US20110039933 S1p-1 receptor agonists |
| 02/17/2011 | US20110039898 Method for scavenging free radicals and inhibiting tyrosinase and melanin |
| 02/17/2011 | US20110039891 Methods for treating a disease in which Rho kinase is involved |
| 02/17/2011 | US20110039882 Phosphodiesterase 10a inhibitor |
| 02/17/2011 | US20110039877 Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis |
| 02/17/2011 | US20110039839 Cyanopyrroles |
| 02/17/2011 | US20110039802 Npy y5 antagonist |
| 02/17/2011 | US20110039781 Treatment of Conditions Related to Cecal Ligation Shock |
| 02/17/2011 | US20110039759 Use of Secretin-Receptor Ligands in Treatment of Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD) |
| 02/17/2011 | US20110038963 Combined effects of nutrients on proliferation of stem cells |
| 02/17/2011 | US20110038960 Preparation and use of a plant extract from solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin d3 glycosides and quercetin glycosides |
| 02/17/2011 | US20110038954 Calcium-rich alkaline power produced from processed mollusc shells |
| 02/17/2011 | US20110038897 Oral controlled release formulations |
| 02/17/2011 | US20110038896 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/17/2011 | US20110038854 Strategy for homo- or hetero-dimerization of various proteins in solution and in cell |
| 02/17/2011 | US20110038851 Treatment of synucleinopathies |
| 02/17/2011 | US20110038834 Novel avian cytokines and genetic sequences encoding same |
| 02/17/2011 | US20110038790 Treatment and prophylaxis of amyloidosis |
| 02/17/2011 | CA2771022A1 Photochemical internalization method |
| 02/17/2011 | CA2771021A1 Photosensitizing compositions |
| 02/17/2011 | CA2769695A1 Pharmaceutical composition and administrations thereof |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2284159A1 5-hydroxypyrimidine-4-carboxamide compound |
| 02/16/2011 | EP2283869A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283868A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283865A1 Method of increasing testosterone and related steroid concentrations in women |
| 02/16/2011 | EP2283863A1 Model and method for angiogenesis inhibition |
| 02/16/2011 | EP2283845A1 Sustained release drug delivery system containing codrugs |
| 02/16/2011 | EP2283842A1 Tamper-resitant oral opioid agonist formulations |
| 02/16/2011 | EP2283834A2 Therapeutic compositions comprising ketone bodies or their precursors |
| 02/16/2011 | EP2282742A1 Inhibitors of fatty acid amide hydrolase |
| 02/16/2011 | EP1469077B1 Cell-specific expression/replication vector |
| 02/16/2011 | EP1424080B1 Gnrh agonist combination drugs |
| 02/16/2011 | EP1379498B1 Sulphones which modulate the action of gamma secretase |
| 02/16/2011 | CN1846456B Communication system for wireless microphone |
| 02/16/2011 | CN101978054A Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 02/16/2011 | CN101977600A Protopanaxadiol-type ginsenoside compositions and uses thereof |
| 02/16/2011 | CN101973998A Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use |
| 02/16/2011 | CN101972481A Macromolecular microcarrier and preparation method thereof |
| 02/16/2011 | CN101972329A Medicinal composition for stimulating appetite and promoting growth of pigs and preparation method thereof |
| 02/16/2011 | CN101972308A Summer-heat relieving health protection solution for livestock and poultry and preparation method thereof |
| 02/16/2011 | CN101972286A New application of valeriana jatamansi jones total flavonoids |
| 02/16/2011 | CN101972241A Application of composition containing 2-(3,4-dihydroxyphenyl) ethanol or glycoside thereof in preparing skin-whitening composition |
| 02/16/2011 | CN101972236A Sustained release preparation containing pirfenidone |
| 02/16/2011 | CN101972230A Pirfenidone for suspension and preparation method |
| 02/16/2011 | CN101538245B One-class pyridazinone compounds and preparation method and application thereof |
| 02/16/2011 | CN101361881B Preparation method as protein medicine lysozyme intestinal-tract sorbefacient |
| 02/16/2011 | CN101343323B Anti-interleukins-8 antibody |